Crenezumab (Anti-Amyloid Beta)
Crenezumab (Anti-Amyloid Beta) (A2764-GRP)
Products
Description
Crenezumab (Anti-Amyloid Beta) is a fully humanized immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2764 |
| Target | Beta Amyloid |